Skip to main content
. 2020 Jun 1;201(11):1345–1357. doi: 10.1164/rccm.201810-1838TR

Table 3.

Effects of Treatment for Obstructive Sleep Apnea on Asthma Outcomes

Reference Design/Sample Assessment Results Limitations
CPAP treatment        
         
 Teodorescu et al., 2012 (62) Cross-sectional OSA: SA-SDQ and PSG • ↓ Daytime asthma symptoms (*OR, 0.46) Objective CPAP adherence not available
n = 132 with OSA, 75 on CPAP Asthma: physician diagnosis
         
 Teodorescu et al., 2013 (7) Cross-sectional OSA: PSG • ↓ Risk of severe asthma (more in older vs. younger patients, by 91% vs. 57%) PSG-derived OSA severity or objective CPAP adherence not available
Age 18–59 yr vs. 60–75 yr Asthma: physician diagnosis
n = 140
         
 Kauppi et al., 2016 (97) Longitudinal, retrospective study OSA: physician diagnosis and CPAP ≥3 mo • ↓ Asthma severity (ACT and VAS) Generalizability limited with high CPAP adherence (6.3 h daily)
n = 152 Asthma: on asthma medication
         
 Wang et al., 2017 (63) Longitudinal, retrospective study OSA: PSG • ↓ The annual decline in FEV1 in severe OSA No control group
n = 77 Asthma: spirometry
         
 Lafond et al., 2007 (68) Interventional: CPAP × 6 wk OSA: PSG (AHI ≥ 15/h) and CPAP titration • No difference in methacholine challenge test Per-protocol analysis of 13 patients with ≥4 h daily CPAP use
n = 20 Asthma: ATS criteria • ↑ Asthma-specific quality of life
         
 Serrano-Pariente et al., 2017 (69) Interventional: CPAP × 6 mo OSA: AHI ≥20/h • ↑ Asthma control, disease-specific quality of life No control group
n = 99 Asthma: physician diagnosis • ↓ Bronchial reactivity (reduced proportion of patients with positive bronchodilator response), exhaled NO
         
Other OSA treatments        
         
 Bachour et al., 2016 (71) Cross-sectional survey, n = 303 OSA: referred for oral appliance treatment • ↑ ACT with oral appliance treatment No control group
Asthma, n = 18 Asthma: physician diagnosis and asthma medication use
         
 Omana et al., 2010 (73) Retrospective bariatric cohort OSA: CPAP use • Self-reported improvement in symptoms or cessation of treatment; in asthma 21/31, in OSA 14/32 Lack of validated questionnaire
Follow-up 17 mo, n = 123
Asthma, n = 31 Asthma: use of asthma medications
OSA, n = 32
         
 Simard et al., 2004 (72) Prospective bariatric cohort OSA: self-reported • Self-reported improvement in asthma control in 23/34 Lack of validated questionnaire
Follow-up 2 yr, n = 398 Asthma: self-reported
Asthma, n = 34
OSA, n = 47
OSA and asthma, n = 18

Definition of abbreviations: ↓ = decreased; ↑ = increased; ACT = asthma control test; AHI = apnea–hypopnea index; ATS = American Thoracic Society; CPAP = continuous positive airway pressure; OR = odds ratio; OSA = obstructive sleep apnea; PSG = polysomnography; SA-SDQ = sleep apnea scale of the Sleep Disorders Questionnaire; VAS = visual analog scale.

*

Statistically significant OR.